The role of peptide YY in appetite regulation and obesity
- 2 January 2009
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 587 (1), 19-25
- https://doi.org/10.1113/jphysiol.2008.164269
Abstract
The last decade has witnessed a marked increase in our understanding of the importance of gut hormones in the regulation of energy homeostasis. In particular, the discovery that the gut hormone peptide YY 3-36 (PYY3-36) reduced feeding in obese rodents and humans fuelled interest in the role of PYY3-36 in body weight regulation. Pharmacological and genetic approaches have revealed that the Y2-receptor mediates the anorectic effects of PYY3-36 whilst mechanistic studies in rodents identified the hypothalamus, vagus and brainstem regions as potential sites of action. More recently, using functional brain imaging techniques in humans, PYY3-36 was found to modulate neuronal activity within hypothalamic and brainstem, and brain regions involved in reward processing. Several lines of evidence suggest that low circulating PYY concentrations predispose towards the development and or maintenance of obesity. Subjects with reduced postprandial PYY release exhibit lower satiety and circulating PYY levels that correlate negatively with markers of adiposity. In addition, mice lacking PYY are hyperphagic and become obese. Conversely, chronic PYY3-36 administration to obese rodents reduces adiposity, and transgenic mice with increased circulating PYY are resistant to diet-induced obesity. Moreover, there is emerging evidence that PYY3-36 may partly mediate the reduced appetite and weight loss benefits observed post-gastric bypass surgery. Taken together these findings, coupled with the retained responsiveness of obese subjects to the effects of PYY3-36, suggest that targeting the PYY system may offer a therapeutic strategy to help treat obesity.Keywords
This publication has 62 references indexed in Scilit:
- Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- PYY(3–36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of ratsPeptides, 2008
- Peptide YY3-36 Decreases Reinstatement of High-Fat Food Seeking during Dieting in a Rat Relapse ModelJournal of Neuroscience, 2007
- PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humansNature, 2007
- Peptide YY levels are associated with appetite suppression in response to long-chain fatty acidsPhysiology & Behavior, 2007
- Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsNew England Journal of Medicine, 2007
- Gastrointestinal regulation of food intakeJCI Insight, 2007
- Interaction of Dietary composition and PYY gene expression in diet-induced obesity in ratsJournal of Huazhong University of Science and Technology [Medical Sciences], 2005
- The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathwayBrain Research, 2005
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003